EGFR and non-small cell lung carcinoma: Most of the patients who were tested for EGFR mutation (86.1%) had the most common histological NSCLC subtype of adenocarcinoma,18 reflecting that during the study period only patients with adenocarcinoma were routinely tested for EGFR mutation.